Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,627 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Angiotensin II for the Treatment of Vasodilatory Shock.
Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, Busse LW, Altaweel L, Albertson TE, Mackey C, McCurdy MT, Boldt DW, Chock S, Young PJ, Krell K, Wunderink RG, Ostermann M, Murugan R, Gong MN, Panwar R, Hästbacka J, Favory R, Venkatesh B, Thompson BT, Bellomo R, Jensen J, Kroll S, Chawla LS, Tidmarsh GF, Deane AM; ATHOS-3 Investigators. Khanna A, et al. Among authors: jensen j. N Engl J Med. 2017 Aug 3;377(5):419-430. doi: 10.1056/NEJMoa1704154. Epub 2017 May 21. N Engl J Med. 2017. PMID: 28528561 Free article. Clinical Trial.
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.
Tumlin JA, Murugan R, Deane AM, Ostermann M, Busse LW, Ham KR, Kashani K, Szerlip HM, Prowle JR, Bihorac A, Finkel KW, Zarbock A, Forni LG, Lynch SJ, Jensen J, Kroll S, Chawla LS, Tidmarsh GF, Bellomo R; Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3) Investigators. Tumlin JA, et al. Among authors: jensen j. Crit Care Med. 2018 Jun;46(6):949-957. doi: 10.1097/CCM.0000000000003092. Crit Care Med. 2018. PMID: 29509568 Free PMC article.
Second primary non-myeloid malignancies following intensive treatment for adult acute myeloid leukaemia: a Danish population-based cohort study.
Nielsen NN, Jensen JF, Baech J, Trab T, El-Galaly TC, Schöllkopf C, Ørskov AD, Ommen HB, Granfeldt LS, Kristensen DT, Severinsen MT. Nielsen NN, et al. Among authors: jensen jf. Lancet Reg Health Eur. 2024 Dec 30;50:101204. doi: 10.1016/j.lanepe.2024.101204. eCollection 2025 Mar. Lancet Reg Health Eur. 2024. PMID: 39844882 Free PMC article.
Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition.
Jakobsen MK, Traynor S, Nielsen AY, Dahl C, Staehr M, Jakobsen ST, Madsen MS, Siersbaek R, Terp MG, Jensen JB, Pedersen CB, Shrestha A, Brewer JR, Duijf PHG, Gammelgaard OL, Ditzel HJ, Kirkin AF, Guldberg P, Gjerstorff MF. Jakobsen MK, et al. Among authors: jensen jb. J Exp Clin Cancer Res. 2025 Jan 23;44(1):21. doi: 10.1186/s13046-025-03294-x. J Exp Clin Cancer Res. 2025. PMID: 39844304 Free PMC article.
Initial clinical experience with [177Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial.
Hansen AR, Probst S, Beauregard JM, Viglianti BL, Michalski JM, Tagawa ST, Sartor O, Tutrone RF, Oz OK, Courtney KD, Delpassand ES, Nordquist LT, Osman MM, Chi KN, Sparks R, George N, Hawley SM, Wu W, Jensen JD, Fleshner NE. Hansen AR, et al. Among authors: jensen jd. Front Oncol. 2025 Jan 7;14:1483953. doi: 10.3389/fonc.2024.1483953. eCollection 2024. Front Oncol. 2025. PMID: 39839782 Free PMC article.
PFAS concentrations in the blood of Danish surfers.
Madsen MH, Møller JJ, Ebbehøj NE, Nielsen F, Severinsen MT, Jensen JF, Lenschow SR, Bønløkke JH. Madsen MH, et al. Among authors: jensen jf. Int J Hyg Environ Health. 2025 Jan 20;264:114522. doi: 10.1016/j.ijheh.2025.114522. Online ahead of print. Int J Hyg Environ Health. 2025. PMID: 39836987
6,627 results